Lantheus Holdings (LNTH) Total Current Liabilities (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Total Current Liabilities came in at $333.2 million in Q1 2026, up 34.34% year-on-year from $248.0 million in Q1 2025, and little changed on a QoQ basis from $333.4 million in Q4 2025.

Lantheus Holdings (LNTH) Total Current Liabilities (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Total Current Liabilities data on file, last reported at $333.2 million in Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 34.34% year-over-year to $333.2 million in Q1 2026; TTM through Mar 2026 was $333.2 million, a 34.34% increase from a year earlier, with the FY2025 full-year figure at $333.4 million, up 38.62% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $333.2 million, roughly flat from $333.4 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for LNTH reached as high as $784.1 million in Q3 2024 and fell as low as $154.0 million in Q2 2023.
  • Historically, Total Current Liabilities has averaged $278.9 million across 5 years, with a median of $247.7 million in 2022.
  • Across the five-year window, Total Current Liabilities soared 343.98% in 2024 and slumped 55.76% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $247.7 million in 2022, then declined by 24.36% to $187.4 million in 2023, then climbed by 28.38% to $240.5 million in 2024, then jumped by 38.62% to $333.4 million in 2025, then dropped by 0.08% to $333.2 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $333.2 million in Q1 2026, $333.4 million in Q4 2025, and $346.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 333.17 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 333.17 Mn
Dec 31, 2025 333.42 Mn
Sep 30, 2025 346.84 Mn
Jun 30, 2025 280.13 Mn
Mar 31, 2025 248.00 Mn
Dec 31, 2024 240.53 Mn
Sep 30, 2024 784.08 Mn
Jun 30, 2024 263.29 Mn
Mar 31, 2024 237.20 Mn
Dec 31, 2023 187.35 Mn
Sep 30, 2023 176.60 Mn
Jun 30, 2023 154.04 Mn
Mar 31, 2023 276.39 Mn
Dec 31, 2022 247.70 Mn
Sep 30, 2022 235.98 Mn
Jun 30, 2022 219.02 Mn
Mar 31, 2022 177.66 Mn
Dec 31, 2021 90.50 Mn
Sep 30, 2021 76.90 Mn
Jun 30, 2021 73.83 Mn